Coronavirus Vaccine: Serum Institute to boost production of Covid-19 vaccine doses to 200 million | India Business News

BENGALURU: Serum Institute of India will make as much as 200 million Covid-19 vaccine doses for poorer nations, together with India, subsequent yr, because the Invoice & Melinda Gates Basis and GAVI vaccines alliance have doubled their investment, the corporate mentioned on Tuesday.
The additional price range will assist Serum spice up production of the vaccine applicants from AstraZeneca Percent and Novavax Inc , for supply below the COVAX scheme as early as the primary part of 2021.
The collaboration takes ahead an preliminary settlement signed in August by way of Serum, GAVI and the Gates Basis for 100 million doses to be priced at a most of $three every.
The entire investment supplied is now $300 million, and the expanded collaboration additionally has an possibility for the availability of extra doses as wanted.
The so-called COVAX plan, co-led by way of the International Well being Group (WHO) and GAVI, goals to ship 2 billion vaccine doses world wide by way of the tip of 2021. Greater than 150 international locations have joined the plan, regardless that China and the USA have now not signed up.
The worldwide loss of life toll from Covid-19 handed 1 million on Tuesday, in keeping with a Reuters tally.
India, which leads the sector within the day-to-day reasonable choice of new infections reported, noticed its coronavirus case tally upward push to six.15 million as of Tuesday.